11.26.19 -- eBook: Keeping Up With Continuous Manufacturing
Outsourced Pharma Content Collections
Keeping Up With Continuous Manufacturing
The promise of continuous manufacturing (CM) seems almost limitless in its potential. But what about the reality on the ground? Louis Garguilo, chief editor, Outsourced Pharma, looks at CM initiatives underway, and what might be slowing adoption.
To understand how one company leverages CM, Garguilo caught up with two executives at Novartis. They discuss the role of the technology at Novartis and they believe CM is “a disruptive innovation the likes of which are rarely seen in our industry.” Garguilo then gathers insights from CM experts at Takeda, Patheon, and Rutgers University. Learn how continuous manufacturing will expand and the factors driving it today — even if somewhat slower than anticipated.